Next Article in Journal
Discriminating Benign from Malignant Lung Diseases Using Plasma Glycosaminoglycans and Cell-Free DNA
Next Article in Special Issue
The ABCG2 Transporter Affects Plasma Levels, Tissue Distribution and Milk Secretion of Lumichrome, a Natural Derivative of Riboflavin
Previous Article in Journal
Prenatal Stress and Ethanol Exposure: Microbiota-Induced Immune Dysregulation and Psychiatric Risks
Previous Article in Special Issue
The Influence of Retinol Ointment on Rabbit Skin (Oryctolagus cuniculus) Ion Transport—An In Vitro Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 25
Issue 18
10.3390/ijms25189775
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Role of Divalent Cations in Infections in Host–Pathogen Interaction

by
John A. D’Elia
and
Larry A. Weinrauch
*
Kidney and Hypertension Section, E P Joslin Research Laboratory, Joslin Diabetes Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(18), 9775; https://doi.org/10.3390/ijms25189775
Submission received: 29 July 2024 / Revised: 29 August 2024 / Accepted: 5 September 2024 / Published: 10 September 2024
(This article belongs to the Special Issue Transport of Nutrients and Ions Relevant to Human Pathophysiology)
Browse Figures
Review Reports Versions Notes

Abstract

:
With increasing numbers of patients worldwide diagnosed with diabetes mellitus, renal disease, and iatrogenic immune deficiencies, an increased understanding of the role of electrolyte interactions in mitigating pathogen virulence is necessary. The levels of divalent cations affect host susceptibility and pathogen survival in persons with relative immune insufficiency. For instance, when host cellular levels of calcium are high compared to magnesium, this relationship contributes to insulin resistance and triples the risk of clinical tuberculosis. The movement of divalent cations within intracellular spaces contributes to the host defense, causing apoptosis or autophagy of the pathogen. The control of divalent cation flow is dependent in part upon the mammalian natural resistance-associated macrophage protein (NRAMP) in the host. Survival of pathogens such as M tuberculosis within the bronchoalveolar macrophage is also dependent upon NRAMP. Pathogens evolve mutations to control the movement of calcium through external and internal channels. The host NRAMP as a metal transporter competes for divalent cations with the pathogen NRAMP in M tuberculosis (whether in latent, dormant, or active phase). This review paper summarizes mechanisms of pathogen offense and patient defense using inflow and efflux through divalent cation channels under the influence of parathyroid hormone vitamin D and calcitonin.

1. Introduction

Public health struggles relating to bacterial, viral, or parasitic infection/infestation involve a large percentage of the world population. The expenditures to eradicate debilitating human illnesses brought about by the infections and infestations are extraordinary. Although partial eradication of parasites and their vectors that contribute to human illness may be accomplished, changing climate, mutating organisms, migrating human hosts, famine, and war continue to lead to the need for additional treatments. To develop future therapy, we need a better understanding of how to prevent parasites from piercing the human integument and entering an environment in which they may thrive at the expense of the human organism. Mycobacterium tuberculosis is generally airborne and enters through the pulmonary alveoli. Malarial, trypanosomal, and leishmanial forms enter via an insect bite, schistosomes penetrate the skin of the foot in fresh water, and trichinella or toxoplasma are ingested. Whatever the mode of entry, the battle between parasite and host dominance takes place at the cellular and intracellular levels.
The movement of divalent cations within intracellular spaces contributes to the host defense, causing apoptosis or autophagy of the pathogen. The control of divalent cation flow is dependent in part upon the mammalian natural resistance-associated macrophage protein (NRAMP) in the host [1]. Survival of pathogens such as M tuberculosis within the bronchoalveolar macrophage is also dependent upon NRAMP. Pathogens evolve mutations to control the movement of calcium through external and internal channels. The host NRAMP as a metal transporter competes for divalent cations with the pathogen NRAMP in M tuberculosis (whether in latent, dormant, or active phase) [2]. Divalent cations are the essential coordinators of cellular and subcellular processes, such as gene expression, cell growth, metabolism, structural coordination, and enzymatic function [3,4,5]. In the following sections, we focus on the role of divalent cations in host–pathogen interactions with particular attention to M tuberculosis.
The survival of M tuberculosis within the macrophage is dependent upon elements of a cellular host–pathogen relationship. Elevated host calcium levels may be associated with cell injury and the death of the pathogen (apoptosis). With lower host levels of calcium, M tuberculosis may survive by repair and recycling by a process known as autophagy. Survival mutations used by Mycobacteria include increased efflux of calcium, with a lesser need for autophagy-related vesicles (phagosomes) [6]. The energy from pumps from the family of P-type ATPase drives calcium out of Mycobacteria [7]. Calcium channel blockers may prevent the efflux of calcium from the mycobacterial pathogen. Calcium channel blockers are useful in stopping the efflux of antibiotics from the pathogen during active infection [8,9]. Calcium and magnesium have similar properties, but in some instances, calcium’s role has been found to be highly specific [8,9]. Patients with an increased ratio of host intracellular calcium to magnesium have an elevated risk of insulin resistance/diabetes mellitus [10]. Diabetes mellitus is associated with a three-fold risk of contracting tuberculosis [11].
The storage of calcium in the host endoplasmic reticulum depends upon the interaction between vitamin D, parathyroid hormone, calcitonin hormone, and calmodulin (calcium message transporter). Biologically important divalent ions include calcium (Ca2+), cadmium (Cd2+), copper (Cu2+), iron (Fe2+), magnesium (Mg2+), manganese (Mn2+), selenium (Se2+), and zinc (Zn2+). Table 1a lists the molecular actions of normal concentrations of Ca2+. Table 1b lists the organ system pathology of toxic concentrations of the divalent cations. Mechanisms requiring anions to couple with divalent cations include calcium (Ca2+) and manganese (Mn2+) with hydroxyl (-OH) and carboxyl (C=O) groups, while copper (Cu2+) and cadmium (Cd2+) bind with sulfhydryl (-SH) groups.
Two mechanisms permitting M tuberculosis to remain alive inside of macrophages are the generation of genes controlling the intake/efflux of divalent cations from within the pathogen (3–5) as well as the ability to shut down metabolism and replication into a state of dormancy, by which it can avoid detection by defense mechanisms [12].

2. Hypercalcemia in Clinical Tuberculosis

In one well-studied case report, an outdoor worker in India was admitted to the hospital with new-onset pulmonary tuberculosis. The patient had decreased renal function (serum creatinine = 2.6 mg/dL, estimated glomerular filtration rate ~30 mL/minute; ratio of blood urea nitrogen to serum creatinine elevated (69 mg/dL/serum creatinine 2.6 mg/dL = 26) suggesting dehydration, serum calcium elevated at 14.4 mg/dL (upper limit of normal = 10.4), serum phosphate = 2.5 mg/dL (lower limit of normal = 2.5), vitamin D (1,25 dihydroxy-cholecalciferol) level above normal range, alkaline phosphatase normal, parathyroid hormone level low-normal at 11.7 pg/mL (normal range 8.0–74 pg/mL)). Potential mechanisms for the elevation of serum calcium included dehydration and generation or hyperstimulation of vitamin D through the skin, kidney, and bronchoalveolar epithelium [13].
Clinical hypercalcemia has been observed in patients with new-onset pulmonary tuberculosis. A potential mechanism involves the synthesis of active vitamin D through the action of pulmonary 1-alpha hydroxylase, which converts the 25 (OH) form of cholecalciferol from liver to 1,25 dihydroxy-cholecalciferol, bypassing the usual renal conversion process. Active vitamin D may be expected to increase the intestinal absorption of calcium. The risk for hypercalcemia is greater when thiazide diuretics are in use, since there is no loss of calcium from the distal renal tubule sodium/potassium exchange site. The resolution of higher concentrations of serum calcium may be expected with the completion of a successful course of antibiotics and corticosteroids [14]. With a bronchial lavage, even people with normal levels of serum calcium while under treatment for pulmonary tuberculosis may demonstrate the active production of 1,25 dihydroxy-cholecalciferol from alveolar macrophages and T-lymphocytes [15]. The same process has been described in the pulmonary macrophages of individuals with sarcoidosis, another pulmonary granulomatous disorder [16]. Hypocalcemia during untreated pulmonary tuberculosis has also been described. The active site may be the bronchial K cell, which is able to secrete calcitonin into the circulatory system. A decreased serum calcium level is to be expected if an elevated serum calcitonin inhibits the action of osteoclasts, which remove calcium phosphorus from bones [17]. Table 2 summarizes the hormones that have important effects on serum calcium. Vitamin D, which is synthesized in the liver/kidney as 1,25 dihydroxy-cholecalciferol, but which has bones as an important target goal, can be considered a vitamin that happens to be a hormone as well. The intracellular transmission of the calcium signal is enhanced by its connection with calmodulin. In the inflammation/immunity functions area, there are increased expressions of intranuclear factors [18] such as that of nuclear factor kappa beta. In the cardiac contraction/relaxation with controlled rhythm function area, the calcium signal is enhanced by its calmodulin connection involving excitation–contraction [19,20].
Many instances of hypercalcemia with untreated pulmonary or disseminated (miliary) tuberculosis are reported from climate zones that are warmer, with a longer exposure to sun, increased skin pigmentation, and a greater likelihood of the hypergeneration of vitamin D. Of the countries reporting hypercalcemia before the treatment of new-onset pulmonary or disseminated tuberculosis (Table 3), only Sweden is in a cooler climate zone [21]. The countries in warmer climate zones include Brazil [13], China [22], Greece [23], India [24], Malaysia [25], Nigeria [26], Pakistan [27], and four warmer locations of the United States of America (USA). These locations include Alabama [28], Kentucky [29], Oklahoma [30], and Tennessee [31]. After many years of decreasing incidence of tuberculosis in the USA, an increased incidence was recorded during the COVID pandemic [32] There was a 35% increase in incidence from 2020 (7171 patients per year) to 2023 (9615 patients per year), during which time the earth experienced its warmest summers and winters [33].

3. Calcium and Magnesium Deficiency in Pulmonary Tuberculosis with Multiple Cavities in Persons with or without Diabetes Mellitus

European incidence of pulmonary tuberculosis is currently highest in Romania, where multiple cavities may be discovered during the initial examination [33]. The degree of lung pathology is correlated with having levels of serum calcium and serum magnesium below the normal range [33]. In addition, persons with type 2 diabetes mellitus may be deficient in magnesium [10]. The level of blood glucose above the normal range is inversely related to the degree of deficiency of serum magnesium below the normal range [10]. It stands to reason that replacement of magnesium until levels are normal would be associated with an improvement in glucose control [10].

4. Survival Mechanisms of Mycobacteria Attacked by Macrophages Involve Calcium Extrusion

High levels of calcium are used by mammals to kill single-cell pathogens like M tuberculosis [34]. This cation works whenever it surrounds the pathogen, i.e., when it is unprotected in the lung matrix, where apoptosis occurs rapidly, or relatively protected within an alveolar macrophage. Eventually, the macrophage may digest the pathogen invader with or without the help of calcium ions provided from the host. In some instances, the host/macrophage defense may cause a release of calcium from stores within the pathogen itself, causing immediate apoptosis. A combination of fatal and non-fatal events will result in an attempt by the surviving pathogens to clear the area of cell debris (autophagy). The extrusion of calcium from within the Mycobacterium protects it from rapid apoptosis, but not without some injury. The process of self-repair by the injured pathogen can be carried out while it is living dependently within an alveolar macrophage. The intermediate stage of autophagy involves phagosomes. To keep the process going, there must be a process of continuous extrusion of calcium from the pathogen [6,7]. Genetic controls of toxic levels of calcium are in place for the extrusion of other divalent cations (Cu2+, Mg2+, Mn2+, Zn2+) [35,36,37,38]. The extrusion of calcium from within the pathogen protects it from apoptosis, followed by a process of repair. The repair of mycobacteria held inside of macrophages involves the elimination of injured structures by a process known as autophagy. The early stages of autophagy include the encapsulation of each mycobacterium within a structure called a phagosome. In later stages of autophagy, mature phagosomes merge with different structures called lysosomes. To keep the process of autophagy going, there must be a continuous process of extrusion of calcium from the pathogen [6,7].
The extrusion of cations across membranes often requires energy through the action of ATPases on ATP to release high-energy phosphate [6,7]. The best known continuously active calcium ion pump system is found in muscles that must contract and relax [sarcolemma endoplasmic reticulum pump (SERCA), see Figure 1]. In mycobacteria, the divalent cation transporting pump system for efflux is genetically controlled through a structure referred to as CptE [6,7]. Autophagy of the pathogen (M tuberculosis) is regulated by a process dependent upon the mammalian target of rapamycin (mTOR) [6]. A calcium transporting pump system referred to as CptE in some cells initiates an inflammation cascade involving calmodulin, calcineurin, and nuclear factor kappa beta (nfKB, see Figure 2). Calcineurin inhibitors (cyclosporine, tacrolimus) and calcium channel blockers (amlodipine, nifedipine, diltiazem, verapamil) inhibit this inflammation cascade. Calcineurin, a phosphatase, has a unique anti-inflammatory role to inhibit the merging of phagosomes with lysosomes by means of which the pathogen does not succumb to the later stages of autophagy inside the macrophage [39].
Hypercalcemia is often noted in people with pulmonary tuberculosis. The main cause of hypercalcemia is increased serum concentrations of vitamin D. Other causes are listed in Table 3. Two hormones that affect the release of calcium from bones are parathyroid hormone (stimulating osteoclasts) and calcitonin (inhibiting the binding of parathyroid hormone to the osteoclast). Pro-calcitonin appears to be expressed during inflammation, marked by an increase in C-reactive protein concentration [40,41].

5. Copper (Cu2+) in Elevated Concentrations Can Be Toxic for M Tuberculosis and Kidney Function in Persons with Diabetes Mellitus

Copper is absorbed through the gastrointestinal system and transported to the liver bound to albumin. It can be stored in the liver bound to metallothionein [42]. Its transport to the periphery requires a different binding protein called ceruloplasmin [42]. Its excretion is mainly into the bile. Certain structures whose functions depend upon Cu2+ include Leiden factor V (natural anti-coagulant), cytochrome C oxidase (electron transport system), lysyl oxidase (bone formation), and dopamine monooxygenase (neurotransmitters) [42]. Increased levels of serum and intracellular copper are associated with an increased incidence of both diabetes mellitus [43,44] and a loss of kidney function through fibrosis [38]. The copper-based enzyme system (lysyl oxidase) has an intracellular connection to renal matrix fibrosis by collagen cross-linking [45].
Copper ion (Cu2+) is a reduction/oxidation (redox) agent capable of catalyzing one molecule of hydrogen peroxide (H2O2) and producing two molecules of hydroxyl radical (2OH−). These hydroxyl radicals are toxic to M tuberculosis. In fact, M tuberculosis is more susceptible to the redox products of Cu2+ than other bacteria such as E. coli. Within macrophages, the concentration of Cu2+ in certain phagosomes is high enough to be toxic for M. avian, a model for M tuberculosis [46]. Copper transport proteins (albumin, transcuprein) are essential for maintaining lower concentrations of copper. Transcuprein is a macroglobulin (270 KD) composed of several smaller proteins ranging from <100 to >100 KD. Transcuprein accepts Cu2+ from albumin so rapidly that it is considered the primary transporter [35]. Copper transport proteins are essential for maintaining lower concentrations of copper in surviving mycobacterial phagosomes. Mutant mycobacteria lacking this transport protein succumb to copper injury. Experimental animals (guinea pigs, mice) demonstrate a one-hundred- to one-thousand-fold decrease in isolates of M tuberculosis in lungs and lymph nodes when their outer membrane cannot eliminate the absorption of Cu2+ [45]. Even in the later stages of autophagy, hydroxyl radicals are lethal agents for surviving mycobacterial phagosomes [47].

6. Zinc (Zn2+) Deficiency in Malnourished Persons with Tuberculosis

Malnourished persons in East Africa (Ethiopia, Tanzania) often have a body mass index <18.5 kg/mg/m2 at the time of diagnosis of pulmonary tuberculosis [48,49]. The levels of Zn2+ are usually below the standard normal range. Adequate nutrition is associated with increased zinc storage, which is useful for macrophage activity against semi-dormant mycobacteria. In response, M tuberculosis has evolved an effective process for efflux of zinc from its internal environment. Since zinc cannot cross biologic membranes by passive diffusion, the energy for active transport is supplied by the action of cation transporting P-type ATPase [50]. Transmembrane proteins existing within the wall outside and inside of the mycobacterium assist in the efflux of Zn2+ from the pathogen. Zn2+ and Cu2+ combinations promoting mycobacterial morbidity/mortality have been thoroughly reviewed [51].

7. Iron (Fe2+) Deficiency and Excess May Participate in the Clinical Course of Pulmonary Tuberculosis

Malnutrition in the host is often accompanied by iron-deficiency anemia, which hinders the delivery of oxygen to the peripheral tissues. Lower levels of iron and ferritin, which are indictors of reduced reserves of circulating and stored iron, prior to the diagnosis of pulmonary tuberculosis are associated with treatment failure [52]. These deficiencies are more likely when sputum samples are found to be rapidly culture-positive for M tuberculosis. When a pulmonary macrophage is activated by interferon, phagosomes within the macrophage kill this pathogen. Hepcidin is a protein hormone that is synthesized in the liver and travels to the intestine to regulate iron absorption [53]. It also has a toxic effect on M tuberculosis. Elevated levels of either ferritin or hepcidin (iron overload or ferroptosis) have been observed in persons with an increased risk of tuberculosis infection [54]. On the other hand, a hepcidin deficiency is seen in persons with hepatitis C or with hemochromatosis. Another defense mechanism directed against M tuberculosis involves the generation of carbon monoxide (CO) through the action of heme oxygenase [55]. The result of carbon monoxide toxicity may be dormancy rather than death for M tuberculosis. Dormancy involves the expenditure of the smallest amount of energy possible through the elimination of functions like replication which are not immediately necessary [55]. Dormancy eliminates both the virulence of the pathogen and its detection by defense mechanisms of the host [12].

8. Magnesium (Mg2+)

Magnesium has a unique function in the RNA of Mycobacterium tuberculosis. Since magnesium (Mg2+) is abundantly available in the environment, it will readily combine with sections of RNA that are negatively charged. Structures within M tuberculosis RNA may be altered by conformational changes. These alterations may have consequences in the expression of genes. A portion of RNA (riboswitch) contains a section (M Box) which is conformationally stable. RNA is strongly electronegative. The binding of Mg2+ to the M box of M tuberculosis has consequences for mutational changes in protein structure, virulence, and accessibility to treatment [55]. Circular dichroism spectroscopy is helpful in imaging secondary structures before and after reactions (binding of ions, oxidative phosphorylation) as a way of understanding tertiary conformation. Circular dichroism uses far ultraviolet light (wavelength of 190–250 nm) along with near ultraviolet light (wavelength of 250–390 nm) to image sulfide bonds, amino acid residues, the orientation of bases, and peptide bonds. Divalent cations (Mg2+, Sr2+) can bind to the RNA of M tuberculosis and B subtilis [56]. When used for the analysis of divalent cation binding, it was found that there were no substantial differences between B subtilis bonds with Mg2+ and Sr2+. However, the binding of Mg2+ was favored over the binding of Sr2+ in the M tuberculosis M Box of the riboswitch [57]. Future studies may focus on the conformational changes resulting from the binding of divalent cations in the M Box to explain the effects of mutation upon virulence and antibiotic resistance within epidemics.

9. Manganese (Mn2+) Is Present in Metalloproteins

Manganese-containing enzymes occur at the connection between the cycles of glycolysis and tricarboxylic acid (TCA). Phosphoenolpyruvate decarboxylase is responsible for decreasing three carbons to two at the end of glycolysis, at which point the critical products are either pyruvate or lactate. Acetyl CoA carboxylase is responsible for the production of citrate at the onset of the TCA cycle. A manganese-containing enzyme (arginase) occurs at the terminus of the urea cycle, at which point toxic ammonia is converted to ornithine plus urea [58]. Manganese has two pathways of attack on M tuberculosis surviving within pulmonary macrophages [59]. The first is to directly stimulate tumor necrosis factor (TNF)—related cascades. These pathway proteins include signal-related kinase (ERK) and signal-related c-Jun N-terminal kinase (JNK). These actions inhibit the survival of the pathogen in pulmonary macrophages. The second pathway to attack M tuberculosis is to stimulate TNF-related pathways by the phosphorylation of interferon genes [58]. Inhibitors of arginase are associated with improved blood flow to the heart/kidney in patients with vascular disease secondary to diabetes mellitus. For patients with diabetes, an area of tuberculosis research would be the efficiency of new arginase inhibitors [58].

10. Selenium Ions May Have a Direct Anti-Mycobacterium tuberculosis Effect

Levels of divalent cations such as zinc [50,51], iron [52,53], and selenium [60] are lower in study cohorts with tuberculosis than in matched groups without pulmonary tuberculosis. The correction of malnutrition in patients under treatment for tuberculosis will return levels of divalent cations to the normal range. However, the supplementation of antibiotic prescriptions with prescriptions for deficient cations has not been shown to improve outcomes. Among 23 trials involving 6482 study subjects, there was only a single study to indicate a possible improvement in clinical outcome by supplementing antibiotics with cation salts [61]. There is evidence to indicate that iron levels which are lower during infection may correct after successful antibiotic therapy by the release of the cation from storage sites and by the elimination of the blockade of intestinal absorption by hepcidin [62,63]. At some point during the treatment for pulmonary tuberculosis, it may become appropriate to restore selenium levels. Experience with selenium supplements revealed a narrow therapeutic window. As a result, the use of nanoparticles began [64]. This form of treatment alone [65,66] or in hybrid with an antibiotic [67,68] has generally met with success.

11. Pulmonary Tuberculosis/COVID-19 Coinfection

The affinity for divalent cations may explain the symptoms of long COVID in survivors. Co-infection with other virus mechanisms may involve calcium movement through external channels or internal pathways. Analyses of case reports from areas where active tuberculosis is endemic have confirmed the hypothesis that the mortality rate must be higher for the co-infection than for either infection separately [69]. The complications of long COVID may include diminished memory/cognition, migraine headache, ischemic cerebrovascular attack with or without seizure, movement/musculoskeletal disorders with or without tremor, and a form of paralysis called Guillain–Barre syndrome [70]. A partial biochemical explanation for neurogenic stress/senescence may be the result of the affinity spectrum for Ca2+ and Cu2+ [71] which exists for certain amino acids (valine, glycine, lysine, leucine, phenylalanine). Calcium deposition salts (oxalate, phosphate) are thought to contribute to interference in critical points of electrical/mechanical signaling. This senescence mechanism may have positive side effects by inhibiting melanoma [72] and colorectal neoplasia [73] pathways in animal models. The affinity of calcium for structures performing the function of an anion, such as carbonate, citrate, chloride, oxalate, phosphate, sulfate, and urate, covers a wide range of molecular weights.
The outer layer envelopes of MERS corona viruses and SARS-CoV viruses [74] contain transmembrane channels for the movement of divalent calcium (Ca2+). In some studies, surface proteins take five-sided configurations (pentagons). An analysis of SARS-CoV E channel activity found the surface charges of proteins/lipids to be useful for the modulation of ion transit [75]. Calcium channel blockers may be protective in life-threatening adult respiratory syndrome infections during which intracellular calcium shifts into the cytoplasm from stores in the endoplasmic reticulum can be toxic to the bronchial epithelium/pulmonary alveoli [76]. The specific mechanism of benefit of calcium channel blockers (amlodipine, verapamil) in multi-drug-resistant pulmonary tuberculosis appears to be the shutting down of efflux channels by which the M tuberculosis rids itself of potentially lethal antibiotics [76]. In one study, COVID-19 patients treated with amlodipine for hypertension had a lower mortality rate than the controls not receiving a calcium channel blocker [77]. The mechanisms of clinical benefit of calcium channel blockers in viral infections may be like those in bacterial infections. These mechanisms would also involve calcium channels with ion pumps for movement against gradients [78]. Additional virus species which have been studied for voltage-dependent calcium channels potentially responsive to calcium channel blockers include delta-corona [79], dengue [80], Ebola [81], hepatitis C [82], influenza A [83,84], rota [85], and West Nile [86]. Interest in tuberculosis/influenza coinfection increases whenever an influenza epidemic occurs as well as when seasonal case numbers increase [86]. Studies have indicated that patients with pulmonary tuberculosis may be more susceptible to invasive influenza infection. In addition, episodes of influenza infection may be associated with a lack of immune protection from invasive pulmonary tuberculosis [87,88]. A mouse study has demonstrated a 100% mortality with coinfection of influenza virus and tuberculosis, as opposed to a 5% mortality with influenza virus infection alone [88]. Certain bacteria (Cholera vibrio, M tuberculosis) and viruses (Ebola, Dengue, influenza) have been shown to utilize host endo-lysosomal cation channels for the transport of nutrients [89].

12. Calcium (CA2+) Mechanisms in Persons with Diabetes Mellitus as a Risk Factor for Tuberculosis and Parasitic Disorders

There is no convincing evidence that persons with pulmonary tuberculosis have a greater risk of new-onset diabetes mellitus than other forms of pneumonia. Persons with diabetes mellitus experience an increased risk of complications of invasive tuberculosis than persons without diabetes mellitus. The increased risk of complications of pulmonary tuberculosis experienced by persons with diabetes mellitus may be explained in part by the decreased activity of macrophages, monocytes, and T-lymphocytes [90].
Relatively lower calcium and vitamin D levels have been described in a review of patients with type 2 diabetes mellitus [91]. The ratio of calcium to magnesium is higher in persons with diabetes mellitus than without diabetes. Therefore, the level of magnesium is also lower in the study group with diabetes mellitus. In addition to levels of serum calcium and serum magnesium being lower than normal in persons with diabetes mellitus, the level of magnesium is inversely related to the degree of pulmonary injury in persons with tuberculosis [10].
As part of the immunologic phase of beta cell destruction in type 1 diabetes, a higher intracellular calcium concentration is noted. Excessive intracellular calcium concentrations cause apoptosis in the Beta cells of the Islets of Langerhans. Thioredoxin-interacting protein, associated with Beta cell dysfunction, may be reversed with glucagon-like peptide receptor agonism and Ca2+ channel blockade [91,92,93,94,95]. Vitamin D and calcium (Ca2+) are associated with multiple reactions culminating in the secretion of insulin [96]. Several of these reactions include the promotion of the expression of the insulin gene [90] and the organization of the binding of Ca2+ in the cytoplasm of Beta cells by the protein calbindin [96] along with the regulation of oscillations of Ca2+ in the cytoplasm of Beta cells, by which the secretion of insulin occurs in a pulsatile rhythm. The activation of endopeptidase promotes exocytosis of insulin from Beta cells [97]. Intravenous insulin infusion in a pulsatile rhythm was found to be superior to continuous infusions with intermittent injections, causing a reduction in glycohemoglobin A1c from levels greater than 8% down to 7.0%, along with the elimination of serious low glucose events [98]. This was also true for the preservation of kidney function in a longitudinal study of individuals with type 1 diabetes with albuminuria [99].
Ion channels allow calcium, sodium, and potassium to pass through cell membranes according to electrical gradients which are strengthened every time the process is repeated. Since calcium is central to neuromuscular function, calcium channels are useful to Schistosomes (haematobium, japonicum, mansoni) in their fresh water free swimming phases (miracidia, cercariae). Praziquantel is the leading agent against Schistosomes. One of the targets of praziquantel is the family of ion channels known as transient receptor potentials (TRP) [100]. In mammals, TRP channel A1 interacts with sensory (light, chemical), pain (nociceptive), and inflammation cascade signals. Some evidence indicates a stimulation of the host (mammal) TRP by praziquantel as an additional mode of defense. The intracellular message of TRP may be transmitted according to the concentration of Ca2+. Wide-ranging research indicates TRP interaction with cell functions like autophagy/apoptosis [12], tumor initiation/progression [101], and inflammation/nociception [102].

13. Chelation Therapy

Chelation therapy for the reduction of toxic levels of divalent cations has become a subject of extensive study (Table 4). A systematic review and meta-analysis of the prevention of cardiovascular complications with chelation therapy [103] involved the use of ethylenediamine tetra acetic acid (EDTA) = C10H16N2O8. This review/meta-analysis emphasized studies of individuals with diabetes mellitus who achieved clinical improvement goals through the application of chelation protocols [101]. While most of the chelation projects report a removal of calcium, several focus specifically upon lead [104,105,106] or cadmium [107,108,109]. Additional studies present results with chelation of the entire list of divalent cations [110,111,112,113,114,115], which might be present in the air or water or soil as environmental contaminants.

14. Discussion of New Concepts for Development of Medications against Pulmonary Tuberculosis

A new approach involving enzymes of M tuberculosis uses three-dimensional imaging to determine the site for the attachment of cadmium (atomic weight 112 g). The use of one of the heavier divalent cations enables the demonstration of the unfolding (denaturation) of the protein enzyme [116]. Other novel uses of three-dimensional molecular imaging may identify sites that can be targeted to interfere with critical M tuberculosis survival and pathogenicity.
The success of the bacillus pathogen M tuberculosis in surviving the defense mechanisms of the host has been attributed to its ability to remain alive in a relatively dormant state after being ingested by pulmonary macrophages (Table 5). Given this protected environment, antibiotics and toxins may be unable to directly confront the invader. One technical problem that inhibits research is the slow growth of M smegmatis, which is safer for individuals working in the laboratory [117]. Genomic adaptations to the intake and efflux of divalent cations for their nutritional values vs. their cellular toxicities are being reported in remarkable detail [118].
Another instance where remarkable detail has emerged involves the secretion of a tuberculosis necrotizing toxin, which can kill a macrophage infected with M tuberculosis [117]. Five required reactions control the opening of exit passages for the toxin to leave a particular member of M tuberculosis. When the necrotizing toxin reaches the cytosol of the macrophage, the work of killing the macrophage proceeds by attacks on its walls. This process is called permeabilization [118,119].
Current research highlights the tug-of-war between the pathogen and the host in the acquisition of an adequate number of divalent cations for survival within a macrophage as opposed to the flooding of the macrophage cytosol with excess amounts of divalent cations, such as calcium/copper/zinc, that will serve as toxins [115]. The failure of the human host defense mechanisms to detect a dormant state of M tuberculosis [9] allows this pathogen sufficient time to create nodular granulomata [120]. A transthoracic needle biopsy of these solitary nodes will reveal live mycobacteria [121].
A channel for Ca2+, Na1+, and K1+ (peizo1) on the surface of the red blood cell (RBC) controls the shape and the surface contour of the RBC when stimulated mechanically [122]. A frequent form of stimulation is stretching. The concave shape can become flat while the smooth surface can become spindly, like that of a hedgehog or a sea urchin. The process of the development of surface spines is called echinocytosis. Certain parts of Africa, where there is the problem of red cell hemolysis due to the assumption of the shape of a sickle, have reported protection from infestation with P falciparum. The protection occurs with the sickle trait heterozygous state (SA) but not with the homozygous state (SS) [123]. Certain parts of Africa may also experience protection from infestation by P falciparum if there is a mutation in the gene for the peizo1 channel [124]. Alterations in shape and surface contours present a barrier to attachment and adherence of the merozoite phase of P falciparum. While the entry of merozoites is blocked by this mutation in the gene for expression of the peizo1 ion channel, there is no impediment to egress [122]. Concentrations of the cations (Ca2+, Na1+, K1+) are also changed following the mechanical stimulation of the piezo1 channel. Intracellular levels of Ca2+ are increased, which generally favors the process of egress of the merozoite. Dehydration was suggested by an elevation of sodium greater than potassium [121]. A unique experimental mouse model quickly succumbed to cerebral malaria following invasion with Plasmodium species. The use of new pharmacological agents which activated the gene for expression of the peizo1 gene demonstrated a dramatic protection from invasive Plasmodium species [122]. The mechanism appeared to be the inhibition of adhesion to the outer surface of the lipid bilayer.
Three-dimensional imaging techniques identify the molecular physiochemical structural sites of enzyme proteins. This permits the design of new antibiotics combining efficiency with reduced side effects. Divalent cations may be useful in antimicrobials by binding to reactive sites. In addition to the design of new antibiotics, calcium channel blockers may represent important adjuncts by preventing the efflux of bactericides from the pathogen, permitting a lower dosage and fewer side effects.
One of the more difficult future research topics will be the development of testing to detect and/or attack dormant pathogens within macrophages before they reach permanent safety inside of a nodule. Chagas disease cardiomyopathy caused by T cruzi infestation is potentially fatal. By means of CRISPR techniques, work with pluripotent stem cell-derived cardiomyocytes has developed the capacity to track the intracellular movement of calcium. This technique, involving calcium indicator proteins, may be applied to other intracellular pathological processes in which functions such as rhythmical contraction can be analyzed. The CRISPR–Cas9 system enables the imaging of conformational changes during the activity of enzymes using magnesium ions. Two sites on the DNA must be cut simultaneously to ensure new DNA for a desired endpoint (mutation, stem cell conversion). Dr. Hong Li and associates at Florida State University show how magnesium ions (Mg2+) are imaged as a chemical bond is broken through the CRISPR–Cas9 technique [56].
In some areas, the twindemic of tuberculosis and malaria may attack a population at the same time. Recently, malaria has returned to the United State of America after having been proclaimed eradicated 75 years ago. Although global warming has often been blamed, an editorial in The Lancet suggested that urban growth, international rapid transit, and drug resistance were as important as climate change [125,126]. Medication resistance becomes more likely when the host is attacked by different pathogens at the same time [127] and when multiple antimicrobials are prescribed in persons immunosuppressed by malnutrition [128,129,130]. Of particular concern is the capacity of pathogens (M tuberculosis, P falciparum) to enhance drug resistance by utilizing calcium channels for drug extrusion [131]. Calcium channel blocking agents (verapamil, diltiazem, amlodipine) may be useful as inhibitors of drug extrusion by pathogens and require additional study (Table 5) [7,76,77,131,132]. Possible parallels for future treatment development may be associated with recent studies of transmembrane conductance. Single cell parasites (E histolytica, T gondii, L donovani, T cruzi, P falciparum) are the target of recent studies of transmembrane intake conductance of nutrients and excretion conductance of waste. One approach is the patch-clamp technique, which quantitates the transit of ions (Na1+, K1+, Ca2+, Mg2+) through lipid bilayers that would otherwise be impermeable [132,133]. The protein and lipid components of transit channels organize the gradients of membrane potentials [132]. Ions move through the channels according to their concentration gradients and/or their electrochemical gradients.

Author Contributions

J.A.D. and L.A.W. participated in all aspects. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Agranoff, D.; Monahan, I.M.; Mangan, J.A.; Butcher, P.D.; Krishna, S. Mycobacterium tuberculosis expresses a novel pH-dependent divalent cation transporter belonging to the Nramp family. J. Exp. Med. 1999, 190, 717–724. [Google Scholar] [CrossRef] [PubMed]
  2. Weiss, G.; Carver, P.L. Role of divalent cations in infectious disease susceptibility and outcome. Clin. Microbiol. Infect. 2018, 24, 16–23. [Google Scholar] [CrossRef] [PubMed]
  3. Cuculis, L.; Zhao, C.; Abil, Z.; Zhao, H.; Shukla, D.; Schroeder, C.M. Divalent cations promote TALE DNA-binding specificity. Nucleic Acids Res. 2020, 48, 1406–1422. [Google Scholar] [CrossRef] [PubMed]
  4. López-Laguna, H.; Sánchez, J.; Unzueta, U.; Mangues, R.; Vázquez, E.; Villaverde, A. Divalent Cations: A Molecular Glue for Protein Materials. Trends Biochem Sci. 2020, 45, 992–1003. [Google Scholar] [CrossRef]
  5. Vashishtha, A.K.; Wang, J.; Konigsberg, W.H. Different Divalent Cations Alter the Kinetics and Fidelity of DNA Polymerases. J. Biol. Chem. 2016, 30, 291. [Google Scholar] [CrossRef]
  6. Garg, R.; Borbora, S.M.; Bansia, H.; Rao, S.; Singh, P.; Verma, R.; Balaji, K.N.; Nagaraja, V. Mycobacterium tuberculosis calcium pump CtpF Modulates the Autophagosome in an mTOR-Dependent Manner. Front. Cell Infect. Microbiol. 2020, 10, 461. [Google Scholar] [CrossRef]
  7. Maya-Hoyos, M.; Rosales, C.; Novoa-Aponte, L.; Castillo, E.; Soto, C.Y. The P-type ATPase CtpF is a plasma membrane transporter mediating calcium efflux in Mycobacterium tuberculosis cells. Heliyon 2019, 5, e02852. [Google Scholar] [CrossRef]
  8. Lee, C.C.; Lee, M.G.; Hsu, W.T.; Park, J.Y.; Porta, L.; Liu, M.A.; Chen, S.C.; Chang, S.C. Use of Calcium Channel Blockers and Risk of Active Tuberculosis Disease: A Population-Based Analysis. Hypertension 2021, 77, 328–337. [Google Scholar] [CrossRef]
  9. D’Elia, J.A.; Weinrauch, L.A. Gated calcium channel and mutation mechanisms in multidrug-resistant tuberculosis. Int. J. Mol. Sci. 2023, 24, 9670. [Google Scholar] [CrossRef]
  10. Shah, I.U.; Sameen, A.; Manzoor, M.F.; Ahmed, Z.; Gao, J.; Farooq, U.; Siddiqi, S.M.; Siddique, R.; Habib, A.; Sun, C.; et al. Association of dietary calcium, magnesium, and vitamin D with type 2 diabetes among US adults: National health and nutrition examination survey 2007–2014-A cross-sectional study. Food Sci. Nutr. 2021, 9, 1480–1490. [Google Scholar] [CrossRef]
  11. Restrepo, B.I. Diabetes Mellitus and tuberculosis. Microbiol. Spectr. 2016, 4, TNM 17-0023-2016. [Google Scholar] [CrossRef] [PubMed]
  12. Gengenbacher, M.; Kaufmann, S.H. Mycobacterium tuberculosis: Success through dormancy. FEMS Microbiol. Rev. 2012, 36, 514–532. [Google Scholar] [CrossRef] [PubMed]
  13. Rajendra, A.; Mishra, A.K.; Francis, N.R.; Carey, R.A. Severe hypercalcemia in a patient with pulmonary tuberculosis. J. Family Med. Prim. Care. 2016, 5, 509–511. [Google Scholar] [CrossRef] [PubMed]
  14. Araujo, C.A.; Araujo, N.A.; Daher, E.F.; Oliveira, J.D.; Kubrusly, M.; Duarte, P.M.; Silva, S.L.; Araujo, S.M. Resolution of hypercalcemia and acute kidney injury after treatment for pulmonary tuberculosis without the use of corticosteroids. Am. J. Trop. Med. Hyg. 2013, 88, 592–595. [Google Scholar] [CrossRef]
  15. Cadranel, J.; Garabedian, M.; Milleron, B.; Guillozo, H.; Akoun, G.; Hance, A.J. 1,25(OH)2D2 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis. J. Clin. Invest. 1990, 85, 1588–1593. [Google Scholar] [CrossRef]
  16. Adams, J.S.; Sharma, O.; Gacad, M.A.; Singer, F.R. Metabolism of 25 hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J. Clin. Investig. 1983, 72, 1856–1860. [Google Scholar] [CrossRef]
  17. Hafiez, A.A.; Abdel-Hafez, M.A.; Salem, D.; Abdou, M.A.; Helaly, A.A.; Aarag, A.H. Calcium homeostasis in untreated tuberculosis. 1—Basic study. Kekkaku 1990, 65, 309–316. [Google Scholar]
  18. Rusciano, M.R.; Sommariva, E.; Douin-Echinard, V.; Ciccarelli, M.; Poggio, P.; Maione, A.S. CaMKII Activity in the Inflammatory Response of Cardiac Diseases. Int. J. Mol. Sci. 2019, 20, 4374. [Google Scholar] [CrossRef]
  19. Junho, C.V.C.; Caio-Silva, W.; Trentin-Sonoda, M.; Carneiro-Ramos, M.S. An Overview of the Role of Calcium/Calmodulin-Dependent Protein Kinase in Cardiorenal Syndrome. Front. Physiol. 2020, 11, 735. [Google Scholar] [CrossRef]
  20. Maier, L.S.; Bers, D.M. Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovasc. Res. 2007, 73, 631–640. [Google Scholar] [CrossRef]
  21. Lind, L.; Ljunghall, S. Hypercalcemia in pulmonary tuberculosis. Ups. J. Med. Sci. 1990, 95, 157–160. [Google Scholar] [CrossRef] [PubMed]
  22. Chan, T.Y.; Poon, P.; Pang, J.; Swaminathan, R.; Chan, C.H.; Nisar, M.; Williams, C.S.; Davies, P.D. A study of calcium and vitamin D metabolism in Chinese patients with pulmonary tuberculosis. J. Trop. Med. Hyg. 1994, 97, 26–30. [Google Scholar] [PubMed]
  23. Roussos, A.; Lagogianni, I.; Gonis, A.; Ilias, I.; Kazi, D.; Patsopoulos, D.; Philippou, N. Hypercalcaemia in Greek patients with tuberculosis before the initiation of anti-tuberculosis treatment. Respir. Med. 2001, 95, 187–190. [Google Scholar] [CrossRef] [PubMed]
  24. John, S.M.; Sagar, S.; Aparna, J.K.; Joy, S.; Mishra, A.K. Risk factors for hypercalcemia in patients with tuberculosis. Int. J. Mycobacteriol. 2020, 9, 7–11. [Google Scholar] [CrossRef] [PubMed]
  25. Liam, C.K.; Lim, K.H.; Srinivas, P.; Poi, P.J. Hypercalcaemia in patients with newly diagnosed tuberculosis in Malaysia. Int. J. Tuberc. Lung. Dis. 1998, 2, 818–823. [Google Scholar]
  26. Ali-Gombe, A.; Onadeko, B.O. Serum calcium levels in patients with active pulmonary tuberculosis. Afr. J. Med. Sci. 1997, 26, 67–68. [Google Scholar]
  27. Soofi, A.; Malik, A.; Khan, J.; Muzaffar, S. Severe hypercalcemia in tuberculosis. J. Pak. Med. Assoc. 2004, 54, 213–215. [Google Scholar]
  28. Sullivan, J.N.; Salmon, W.D., Jr. Hypercalcemia in active pulmonary tuberculosis. South Med. J. 1987, 80, 572–576. [Google Scholar] [CrossRef]
  29. Cipola, L.; Roy, T.M.; Gardner, R.P. Symptomatic hypercalcemia pulmonary tuberculosis. J. Ky. Med. Assoc. 1989, 87, 13–16. [Google Scholar]
  30. Pruitt, B.; Onarecker, C.; Coniglione, T. Hypercalcemic crisis in a patient with pulmonary tuberculosis. J. Okla. State Med. Assoc. 1995, 88, 518–520. [Google Scholar]
  31. Hourany, J.; Mehta, J.B.; Hourany, V.; Byrd, R.P., Jr.; Roy, T.M. Hypercalcemia and pulmonary tuberculosis in east Tennessee. Tenn. Med. 1997, 90, 493–495. [Google Scholar] [PubMed]
  32. Williams, P.M.; Pratt, R.H.; Walker, W.L.; Price, S.F.; Stewart, R.J.; Feng, P.I. Tuberculosis—United States, 2023. MMWR Morb. Mortal. Wkly. Rep. 2024, 73, 265–270. [Google Scholar] [CrossRef] [PubMed]
  33. Cioboata, R.; Vasile, C.M.; Bălteanu, M.A.; Georgescu, D.E.; Toma, C.; Dracea, A.S.; Nicolosu, D. Evaluating Serum Calcium and Magnesium Levels as Predictive Biomarkers for Tuberculosis and COVID-19 Severity: A Romanian Prospective Study. Int. J. Mol. Sci. 2023, 25, 418. [Google Scholar] [CrossRef] [PubMed]
  34. Trimble, W.S.; Grinstein, S. TB or not TB: Calcium regulation in mycobacterial survival. Cell 2007, 130, 12–14. [Google Scholar] [CrossRef]
  35. Goode, C.A.; Dinh, C.T.; Linder, M.C. Mechanism of copper transport and delivery in mammals: Review and recent findings. Adv. Exp. Med. Biol. 1989, 258, 131–144. [Google Scholar]
  36. White, J.R.; Campbell, R.K. Magnesium and Diabetes: A review. Ann. Pharmacother. 1993, 27, 775–780. [Google Scholar] [CrossRef]
  37. Padilla-Benavides, T.; Long, J.E.; Raimunda, D.; Sassetti, C.M.; Argüello, J.M. A novel P(1B)-type Mn2+-transporting ATPase is required for secreted protein metalation in mycobacteria. J. Biol. Chem. 2013, 288, 11334–11347. [Google Scholar] [CrossRef]
  38. Botella, H.; Peyron, P.; Levillain, F.; Poincloux, R.; Poquet, Y.; Brandli, I.; Wang, C.; Tailleux, L.; Tilleul, S.; Charrière, G.M.; et al. Mycobacterial p(1)-type ATPases mediate resistance to zinc poisoning in human macrophages. Cell Host Microbe. 2011, 10, 248–259. [Google Scholar] [CrossRef]
  39. Jayachandran, R.; Sundaramurthy, V.; Combaluzier, B.; Mueller, P.; Korf, H.; Huygen, K.; Miyazaki, T.; Albrecht, I.; Massner, J.; Pieters, J. Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin. Cell 2007, 1, 37–50. [Google Scholar] [CrossRef]
  40. Kang, Y.J.; Park, H.; Park, S.B.; Lee, J.; Hyun, H.; Jung, M.; Lee, E.J.; Je, M.A.; Kim, J.; Lee, Y.S.; et al. High Procalcitonin, C-Reactive Protein, and α-1 Acid Glycoprotein Levels in Whole Blood Samples Could Help Rapid Discrimination of Active Tuberculosis from Latent Tuberculosis Infection and Healthy Individuals. Microorg. 2022, 10, 1928. [Google Scholar] [CrossRef]
  41. Kandemir, O.; Uluba, B.; Polat, G.; Sezer, C.; Camdeviren, H.; Kaya, A. Elevation of procalcitonin level in patients with pulmonary tuberculosis and in medical staff with close patient contact. Arch. Med. Res. 2003, 34, 311–314. [Google Scholar] [CrossRef] [PubMed]
  42. Doguer, C.; Ha, J.H.; Collins, J.F. Intersection of Iron and Copper Metabolism in the Mammalian Intestine and Liver. Compr Physiol. 2018, 8, 1433–1461. [Google Scholar] [PubMed]
  43. Laouali, N.; MacDonald, C.J.; Shah, S.; El Fatouhi, D.; Mancini, F.R.; Fagherazzi, G.; Boutron-Ruault, M.C. Dietary Copper/Zinc Ratio and Type 2 Diabetes Risk in Women: The E3N Cohort Study. Nutrients 2021, 13, 2502. [Google Scholar] [CrossRef] [PubMed]
  44. Gembillo, G.; Labbozzetta, V.; Giuffrida, A.E.; Peritore, L.; Calabrese, V.; Spinella, C.; Stancanelli, M.R.; Spallino, E.; Visconti, L.; Santoro, D. Potential Role of Copper in Diabetes and Diabetic Kidney Disease. Metabolites 2022, 13, 17. [Google Scholar] [CrossRef]
  45. Gong, D.; Lu, J.; Chen, X.; Reddy, S.; Crossman, D.J.; Glyn-Jones, S.; Choong, Y.S.; Kennedy, J.; Barry, B.; Zhang, S.; et al. A copper(II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-beta activation in the kidneys of rats used as a model of diabetes. Diabetologia 2008, 51, 1741–1751. [Google Scholar] [CrossRef]
  46. Wolschendorf, F.; Ackart, D.; Shrestha, T.B.; Hascall-Dove, L.; Nolan, S.; Lamichhane, G.; Wang, Y.; Bossmann, S.H.; Basaraba, R.J.; Niederweis, M. Copper resistance is essential for virulence of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 2011, 108, 1621–1626. [Google Scholar] [CrossRef]
  47. Nathan, C.; Shiloh, M.U. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 2000, 97, 8841–8848. [Google Scholar] [CrossRef]
  48. Khanna, B.K.; Kumar, R.L.; Mukherjee, P.K.; Chaudhary, A.R.; Kamboj, V.P. Plasma copper and zinc levels in pulmonary tuberculosis. Indian J. Tuberc. 1982, 29, 179–181. [Google Scholar]
  49. Keflie, T.S.; Samuel, A.; Woldegiorgis, A.Z.; Mihret, A.; Abebe, M.; Biesalski, H.K. Vitamin A and zinc deficiencies among tuberculosis patients in Ethiopia. J. Clin. Tuberc. Other Mycobact. Dis. 2018, 12, 27–33. [Google Scholar] [CrossRef]
  50. Boudehen, Y.M.; Faucher, M.; Maréchal, X.; Miras, R.; Rech, J.; Rombouts, Y.; Sénèque, O.; Wallat, M.; Demange, P.; Bouet, J.Y.; et al. Mycobacterial resistance to zinc poisoning requires assembly of P-ATPase-containing membrane metal efflux platforms. Nat. Commun. 2022, 13, 4731. [Google Scholar] [CrossRef]
  51. Neyrolles, O.; Wolschendorf, F.; Mitra, A.; Niederweis, M. Mycobacteria, metals, and the macrophage. Immunol. Rev. 2015, 264, 249–263. [Google Scholar] [CrossRef] [PubMed]
  52. Isanaka, S.; Aboud, S.; Mugusi, F.; Bosch, R.J.; Willett, W.C.; Spiegelman, D.; Duggan, C.; Fawzi, W.W. Iron status predicts treatment failure and mortality in tuberculosis patients: A prospective cohort study from Dar es Salaam, Tanzania. PLoS ONE 2012, 7, e37350. [Google Scholar] [CrossRef] [PubMed]
  53. Sow, F.B.; Florence, W.C.; Satoskar, A.R.; Schlesinger, L.S.; Zwilling, B.S.; Lafuse, W.P. Expression and localization of hepcidin in macrophages: A role in host defense against tuberculosis. J. Leukoc. Biol. 2007, 82, 934–945. [Google Scholar] [CrossRef] [PubMed]
  54. Wang, J.; Cao, H.; Xie, Y.; Xu, Z.; Li, Y.; Luo, H. Mycobacterium tuberculosis infection induces a novel type of cell death: Ferroptosis. Biomed. Pharmacother. 2024, 177, 117030. [Google Scholar] [CrossRef]
  55. Kumar, A.; Deshane, J.S.; Crossman, D.K.; Bolisetty, S.; Yan, B.S.; Kramnik, I.; Agarwal, A.; Steyn, A.J. Heme oxygenase-1-derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon. J. Biol. Chem. 2008, 283, 18032–18039. [Google Scholar] [CrossRef]
  56. Das, A.; Ray, J.; Roth, M.O.; Shu, Y.; Medina, M.L.; Barakar, M.R.; Li, H. Coupled catalytic states and the role of metal coordination in Cas 9. Nat. Catal. 2023, 6, 969–977. [Google Scholar] [CrossRef]
  57. Bahoua, B.; Sevdalis, S.E.; Soto, A.M. Effect of Sequence on the Interactions of Divalent Cations with M-Box Riboswitches from Mycobacterium tuberculosis and Bacillus subtilis. Biochem. 2021, 60, 2781–2794. [Google Scholar] [CrossRef]
  58. Caldwell, R.W.; Rodriguez, P.C.; Toque, H.A.; Narayanan, S.P.; Caldwell, R.B. Arginase: A Multifaceted Enzyme Important in Health and Disease. Physiol. Rev. 2018, 98, 641–665. [Google Scholar] [CrossRef]
  59. Qian, K.; Shan, L.; Shang, S.; Li, T.; Wang, S.; Wei, M.; Tang, B.; Xi, J. Manganese enhances macrophage defense against Mycobacterium tuberculosis via the STING-TNF signaling pathway. Int. Immunopharmacol. 2022, 113, 109471. [Google Scholar] [CrossRef]
  60. Muzembo, B.A.; Mbendi, N.C.; Ngatu, N.R.; Suzuki, T.; Wada, K.; Ikeda, S. Serum selenium levels in tuberculosis patients: A systematic review and meta-analysis. J. Trace Elem. Med. Biol. 2018, 50, 257–262. [Google Scholar] [CrossRef]
  61. Sinclair, D.; Abba, K.; Grobler, L.; Sudarsanam, T.D. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst. Rev. 2011, 11, CD006086, Update in: Cochrane Database Syst. Rev. 2016, 6, CD006086. [Google Scholar] [CrossRef] [PubMed]
  62. Nienaber, A.; Uyoga, M.A.; Dolman-Macleod, R.C.; Malan, L. Iron Status and Supplementation during Tuberculosis. Microorganisms 2023, 11, 785. [Google Scholar] [CrossRef] [PubMed]
  63. Agoro, R.; Mura, C. Iron Supplementation Therapy, A Friend and Foe of Mycobacterial Infections? Pharmaceuticals 2019, 12, 75. [Google Scholar] [CrossRef] [PubMed]
  64. Estevez, H.; Palacios, A.; Gil, D.; Anguita, J.; Vallet-Regi, M.; González, B.; Prados-Rosales, R.; Luque-Garcia, J.L. Antimycobacterial Effect of Selenium Nanoparticles on Mycobacterium tuberculosis. Front. Microbiol. 2020, 11, 800. [Google Scholar] [CrossRef]
  65. Ifijen, I.H.; Atoe, B.; Ekun, R.O.; Ighodaro, A.; Odiachi, I.J. Treatments of Mycobacterium tuberculosis and Toxoplasma gondii with Selenium Nanoparticles. Bionanoscience 2023, 13, 249–277. [Google Scholar] [CrossRef]
  66. Pi, J.; Shen, L.; Yang, E.; Shen, H.; Huang, D.; Wang, R.; Hu, C.; Jin, H.; Cai, H.; Cai, J.; et al. Macrophage-Targeted Isoniazid-Selenium Nanoparticles Promote Antimicrobial Immunity and Synergize Bactericidal Destruction of Tuberculosis bacilli. Angew. Chem. Int. Ed. Engl. 2020, 59, 3226–3323. [Google Scholar] [CrossRef]
  67. Ribeiro, R.C.B.; de Marins, D.B.; Di Leo, I.; da Silva Gomes, L.; de Moraes, M.G.; Abbadi, B.L.; Villela, A.D.; da Silva, W.F.; da Silva, L.C.R.P.; Machado, P.; et al. Anti-tubercular profile of new selenium-menadione conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain and multidrug-resistant clinical isolates. Eur. J. Med. Chem. 2021, 209, 112859. [Google Scholar] [CrossRef]
  68. Lin, W.; Fan, S.; Liao, K.; Huang, Y.; Cong, Y.; Zhang, J.; Jin, H.; Zhao, Y.; Ruan, Y.; Lu, H.; et al. Engineering zinc oxide hybrid selenium nanoparticles for synergetic anti-tuberculosis treatment by combining Mycobacterium tuberculosis killings and host cell immunological inhibition. Front. Cell Infect. Microbiol. 2023, 12, 1074533. [Google Scholar] [CrossRef]
  69. Song, W.M.; Zhao, J.Y.; Zhang, Q.Y.; Liu, S.Q.; Zhu, X.H.; An, Q.Q.; Xu, T.T.; Li, S.J.; Liu, J.Y.; Tao, N.N.; et al. COVID-19 and Tuberculosis Coinfection: An Overview of Case Reports/Case Series and Meta-Analysis. Front. Med. 2021, 8, 657006. [Google Scholar] [CrossRef]
  70. Xu, E.; Xie, Y.; Al-Aly, Z. Long-term neurologic outcomes of COVID-19. Nat. Med. 2022, 28, 2406–2415. [Google Scholar] [CrossRef]
  71. Zhang, X.; Zhang, Y.; Wen, L.; Ouyang, J.L.; Zhang, W.; Zhang, J.; Wang, Y.; Liu, Q. Neurological Sequelae of COVID-19: A Biochemical Perspective. ACS Omega 2023, 8, 27812–27818. [Google Scholar] [CrossRef] [PubMed]
  72. Rose, M.L.; Madren, J.; Bunzendahl, H.; Thurman, R.G. Dietary glycine inhibits the growth of B16 melanoma tumors in mice. Carcinogenesis 1999, 20, 793–798. [Google Scholar] [CrossRef] [PubMed]
  73. Bruns, H.; Kazanavicius, D.; Schultze, D.; Saeedi, M.A.; Yamanaka, K.; Strupas, K.; Schemmer, P. Glycine inhibits angiogenesis in colorectal cancer: Role of endothelial cells. Amino Acids 2016, 48, 2549–2558. [Google Scholar] [CrossRef] [PubMed]
  74. Surya, W.; Li, Y.; Verdià-Bàguena, C.; Aguilella, V.M.; Torres, J. MERS coronavirus envelope protein has a single transmembrane domain that forms pentameric ion channels. Virus Res. 2015, 201, 61–66. [Google Scholar] [CrossRef]
  75. Verdiá-Báguena, C.; Nieto-Torres, J.L.; Alcaraz, A.; Dediego, M.L.; Enjuanes, L.; Aguilella, V.M. Analysis of SARS-CoV E protein ion channel activity by tuning the protein and lipid charge. Biochim. Biophys. Acta. 2013, 9, 1828. [Google Scholar] [CrossRef]
  76. D’Elia, J.A.; Weinrauch, L.A. Calcium Ion Channels: Roles in Infection and Sepsis Mechanisms of Calcium Channel Blocker Benefits in Immunocompromised Patients at Risk for Infection. Int. J. Mol. Sci. 2018, 19, 2465. [Google Scholar] [CrossRef]
  77. Zhang, L.K.; Sun, Y.; Zeng, H.; Wang, Q.; Jiang, X.; Shang, W.J.; Wu, Y.; Li, S.; Zhang, Y.L.; Hao, Z.N.; et al. Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension. Cell Discov. 2020, 6, 96, Erratum in: Cell Discov. 2021, 7, 29. [Google Scholar] [CrossRef]
  78. Olivier, M. Modulation of host cell intracellular Ca2+. Parasitol. Today 1996, 12, 145–150. [Google Scholar] [CrossRef]
  79. Bai, D.; Fang, L.; Xia, S.; Ke, W.; Wang, J.; Wu, X.; Fang, P.; Xiao, S. Porcine deltacoronavirus (PDCoV) modulates calcium influx to favor viral replication. Virology 2020, 539, 38–48. [Google Scholar] [CrossRef]
  80. Dionicio, C.L.; Peña, F.; Constantino-Jonapa, L.A.; Vazquez, C.; Yocupicio-Monroy, M.; Rosales, R.; Zambrano, J.L.; Ruiz, M.C.; Del Angel, R.M.; Ludert, J.E. Dengue virus induced changes in Ca2+ homeostasis in human hepatic cells that favor the viral replicative cycle. Virus Res. 2018, 245, 17–28. [Google Scholar] [CrossRef]
  81. Johansen, L.M.; DeWald, L.E.; Shoemaker, C.J.>; Hoffstrom, B.G.; Lear-Rooney, c.M.; Stossel, A.; Nelson, E.; Delos, S.E.; Simmons, J.A.; Grenier, J.M.; et al. A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity. Sci. Transl. Med. 2015, 7, 290ra289. [Google Scholar] [CrossRef] [PubMed]
  82. Brault, C.; Levy, P.I.; Bartosch, B. Hepatitis C virus-induced mitochondrial dysfunctions. Viruses 2013, 5, 954–960. [Google Scholar] [CrossRef] [PubMed]
  83. Nugent, K.M.; Stanley, J.D. Verapamil inhibits influenza A virus entity. Arch. Virol. 1984, 81, 163–170. [Google Scholar] [CrossRef] [PubMed]
  84. Fujioka, Y.; Nishide, S.; Ose, T.; Suzuki, T.; Kato, I.; Fukuhara, H.; Fujioka, M.; Horiuchi, K.; Satoh, A.O.; Nepal, P.; et al. A Sialylated Voltage-Dependent Ca2+ Channel Binds Hemagglutinin and Mediates Influenza A Virus Entry into Mammalian Cells. Cell Host Microbe 2018, 23, 809–818.e5. [Google Scholar] [CrossRef]
  85. Hyser, J.M.; Utama, B.; Crawford, S.E.; Broughman, J.R.; Estes, M.K. Activation of the endoplasmic reticulum calcium sensor STIM1 and store-operated calcium entry by rotavirus requires NSP4 viroporin activity. J. Virol. 2013, 87, 13579–13588. [Google Scholar] [CrossRef]
  86. Scherbik, S.V.; Brinton, M.A. Virus-induced Ca2+ influx extends survival of west Nile virus-infected cells. J. Virol. 2010, 84, 8721–8731. [Google Scholar] [CrossRef]
  87. Walaza, S.; Cohen, C.; Tempia, S.; Moyes, J.; Nguweneza, A.; Madhi, S.A.; McMorrow, M.; Cohen, A.L. Influenza and tuberculosis co-infection: A systematic review. Influenza Other Respir. Viruses 2020, 14, 77–91. [Google Scholar] [CrossRef]
  88. Bernard, E.; Kreis, B.; le Quang, S. Influence of influenza on tuberculosis. Bull. Acad. Natl. Med. 1962, 146, 139–145. (In French) [Google Scholar]
  89. Chao, Y.K.; Chang, S.Y.; Grimm, C. Endo-Lysosomal Cation Channels and Infectious Diseases. Rev. Physiol. Biochem. Pharmacol. 2023, 185, 259–276. [Google Scholar]
  90. Yorke, E.; Atiase, Y.; Kapalua, J.; Sarfo-Kantanka, O.; Boima, V.; Dey, I.D. The Bidirectional Relationship between Tuberculosis and Diabetes. Tuberc. Res. Treat. 2017, 2017, 1702578. [Google Scholar] [CrossRef]
  91. Pittas, A.G.; Lau, J.; Hu, F.; Dawson-Hughes, B. The role of vitamin D and calcium in type 2 diabetics: A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2007, 92, 2012–2029. [Google Scholar] [CrossRef] [PubMed]
  92. Dandona, P.; Chaudhuri, A.; Ghanim, H. Semaglutide in Early Type 1 Diabetes. N. Engl. J. Med. 2023, 389, 958–959. [Google Scholar] [CrossRef] [PubMed]
  93. Chen, J.; Cha-Molstad, H.; Szabo, A.; Shalev, A. Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein. Am. J. Physiol. Endocrinol. Metab. 2009, 296, E1133–E1139. [Google Scholar] [CrossRef] [PubMed]
  94. Xu, G.; Chen, J.; Jing, G.; Shalev, A. Preventing Beta cell loss in diabetes with calcium channel blockers. Diabetes 2012, 61, 848–856. [Google Scholar] [CrossRef] [PubMed]
  95. Weinrauch, L.A.; D’Elia, J.A. More on Semaglutide in Early Type 1 Diabetes. N. Engl. J. Med. 2024, 390, 291. [Google Scholar]
  96. Maestro, B.; Molero, S.; Bajo, S.; Dávila, N.; Calle, C. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). Cell Biochem. Funct. 2002, 20, 227–232. [Google Scholar] [CrossRef]
  97. Sooy, K.; Schermerhorn, T.; Noda, M.; Surana, M.; Rhoten, W.B.; Meyer, M.; Fleischer, N.; Sharp, G.W.; Christakos, S. Calbindin-D(28k) controls [Ca(2+)](i) and insulin release. Evidence obtained from calbindin-d(28k) knockout mice and beta cell lines. J. Biol. Chem. 1999, 274, 34343–34349. [Google Scholar] [CrossRef]
  98. Aoki, T.T.; Benbarka, M.M.; Okimura, M.C.; Arcangeli, M.A.; Walter, R.M., Jr.; Wilson, L.D.; Truong, M.P.; Barber, A.R.; Kumagai, L.F. Long-term intermittent intravenous insulin therapy and type 1 diabetes mellitus. Lancet 1993, 342, 515–518. [Google Scholar] [CrossRef]
  99. Daily, G.E.; Boden, G.H.; Creech, R.H.; Johnson, D.G.; Gleason, R.E.; Kennedy, F.P.; Weinrauch, L.A.; Weir, M.; D’Elia, J.A. Effects of pulsatile intravenous insulin therapy on the progression of diabetic nephropathy. Metabolism 2000, 49, 1491–1495. [Google Scholar] [CrossRef]
  100. Bais, S.; Greenberg, R.M. Schistosome TRP channels: An appraisal. Int. J. Parasitol. Drugs Drug Resist. 2020, 13, 1–7. [Google Scholar] [CrossRef]
  101. Fliniaux, I.; Germain, E.; Farfariello, V.; Prevarskaya, N. TRPs and Ca2+ in cell death and survival. Cell Calcium 2018, 69, 4–18. [Google Scholar] [CrossRef] [PubMed]
  102. Parenti, A.; De Logu, F.; Geppetti, P.; Benemei, S. What is the evidence for the role of TRP channels in inflammatory and immune cells? Br. J. Pharmacol. 2016, 173, 953–969. [Google Scholar] [CrossRef] [PubMed]
  103. Lamas, G.A.; Navas-Acien, A. Chelation Therapy in Patients with Cardiovascular Disease: A Systematic Review. J. Am. Heart Assoc. 2022, 11, e024648. [Google Scholar]
  104. Lin, J.L.; Lin-Tan, D.T.; Hsu, K.H.; Yu, C.C. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N. Engl. J. Med. 2003, 348, 277–286. [Google Scholar] [CrossRef]
  105. Lamas, G.A.; Ujueta, F.; Navas-Acien, A. Lead and Cadmium as Cardiovascular Risk Factors: The Burden of Proof Has Been Met. J. Am. Heart Assoc. 2021, 10, e018692. [Google Scholar] [CrossRef]
  106. Lustberg, M.; Silbergeld, E. Blood lead levels and mortality. Arch. Intern. Med. 2002, 162, 2443–2449. [Google Scholar] [CrossRef]
  107. Waters, R.S.; Bryden, N.A.; Patterson, K.Y.; Veillon, C.; Anderson, R.A. EDTA chelation effects on urinary losses of cadmium, calcium, chromium, cobalt, copper, lead, magnesium, and zinc. Biol. Trace Elem. Res. 2001, 83, 207–221. [Google Scholar] [CrossRef]
  108. Tellez-Plaza, M.; Guallar, E.; Fabsitz, R.R.; Howard, B.V.; Umans, J.G.; Francesconi, K.A.; Goessler, W.; Devereux, R.B.; Navas-Acien, A. Cadmium exposure and incident peripheral arterial disease. Circ. Cardiovasc. Qual Outcomes 2013, 6, 626–633. [Google Scholar] [CrossRef]
  109. Ujueta, F.; Arenas, I.A.; Diaz, D.; Yates, T.; Beasley, R.; Navas-Acien, A.; Lamas, G.A. Cadmium level and severity of peripheral artery disease in patients with coronary artery disease. Eur. J. Prev. Cardiol. 2019, 26, 1456–1458. [Google Scholar] [CrossRef]
  110. Alam, Z.H.; Ujueta, F.; Arenas, I.A.; Nigra, A.E.; Navas-Acien, A.; Lamas, G.A. Urinary Metal Levels after Repeated Edetate Disodium Infusions: Preliminary Findings. Int. J. Environ. Res. Public Health 2020, 29, 4684. [Google Scholar] [CrossRef]
  111. Ujueta, F.; Navas-Acien, A.; Mann, K.K.; Prashad, R.; Lamas, G.A. Low-Level Metal Contamination and Chelation in Cardiovascular Disease-A Ripe Area for Toxicology Research. Toxicol. Sci. 2021, 181, 135–147. [Google Scholar] [CrossRef] [PubMed]
  112. Chowdhury, R.; Ramond, A.; O’Keeffe, L.M.; Shahzad, S.; Kunutsor, S.K.; Muka, T.; Gregson, J.; Willeit, P.; Warnakula, S.; Khan, H.; et al. Environmental toxic metal contaminants and risk of cardiovascular disease: Systematic review and meta-analysis. BMJ 2018, 362, k3310. [Google Scholar] [CrossRef] [PubMed]
  113. Alissa, E.M.; Ferns, G.A. Heavy metal poisoning and cardiovascular disease. J. Toxicol. 2011, 2011, 870125. [Google Scholar] [CrossRef] [PubMed]
  114. Chen, Y.W.; Yang, C.Y.; Huang, C.F.; Hung, D.Z.; Leung, Y.M.; Liu, S.H. Heavy metals, islet function, and diabetes development. Islets 2009, 1, 169–176. [Google Scholar] [CrossRef]
  115. Ouyang, P.; Gottlieb, S.H.; Culotta, V.L.; Navas-Acien, A. EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes. Curr. Cardiol. Rep. 2015, 17, 96. [Google Scholar] [CrossRef]
  116. Calderon Moreno, R.; Navas-Acien, A.; Escolar, E.; Nathan, D.M.; Newman, J.; Schmedtje, J.F.; Diaz, D.; Lamas, G.A.; Fonseca, V. Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes. J. Clin. Endocrinol. Metab. 2019, 104, 2931–2941. [Google Scholar] [CrossRef]
  117. Singh, K.; Bhakuni, V. Cation induced differential effect on structural and functional properties of Mycobacterium tuberculosis alpha-isopropylmalate synthase. BMC Struct. Biol. 2007, 19, 39. [Google Scholar]
  118. Pajuelo, D.; Tak, U.; Zhang, L.; Danilchanka, O.; Tischler, A.D.; Niederweis, M. Toxin secretion and trafficking by Mycobacterium tuberculosis. Nat. Commun. 2021, 12, 6592. [Google Scholar] [CrossRef]
  119. Salgado, M.; Márquez-Miranda, V.; Ferrada, L.; Rojas, M.; Poblete-Flores, G.; González-Nilo, F.D.; Ardiles, Á.O.; Sáez, J.C. Ca2+ permeation through C-terminal cleaved, but not full-length human Pannexin1 hemichannels, mediates cell death. Proc. Natl. Acad. Sci. USA 2024, 121, e2405468121. [Google Scholar] [CrossRef]
  120. Cook, G.M.; Berney, M.; Gebhard, S.; Heinemann, M.; Cox, R.A.; Danilchanka, O.; Niederweis, M. Physiology of mycobacteria. Adv. Microb. Physiol. 2009, 55, 81–182. [Google Scholar]
  121. Ferreirós, J.; Bustos, A.; Merino, S.; Castro, E.; Dorao, M.; Crespo, C. Transthoracic needle aspiration biopsy: Value in the diagnosis of mycobacterial lung opacities. J. Thorac. Imaging 1999, 14, 194–200. [Google Scholar] [CrossRef] [PubMed]
  122. Lohia, R.; Allegrini, B.; Berry, L.; Guizouarn, H.; Cerdan, R.; Abkarian, M.; Douguet, D.; Honoré, E.; Wengelnik, K. Pharmacological activation of PIEZO1 in human red blood cells prevents Plasmodium falciparum invasion. Cell Mol. Life Sci. 2023, 18, 124. [Google Scholar] [CrossRef] [PubMed]
  123. Luzzatto, L. Sickle cell anaemia and malaria. Mediterr. J. Hematol. Infect. Dis. 2012, 4, e2012065. [Google Scholar] [CrossRef] [PubMed]
  124. Nguetse, C.N.; Purington, N.; Ebel, E.R.; Shakya, B.; Tetard, M.; Kremsner, P.G.; Velavan, T.P.; Egan, E.S. A common polymorphism in the mechanosensitive ion channel PIEZO1 is associated with protection from severe malaria in humans. Proc. Natl. Acad. Sci. USA 2020, 117, 9074–9081. [Google Scholar] [CrossRef]
  125. Reiter, P. Global warming and vector borne disease in temperate regions. Lancet 1998, 351, 839–840. [Google Scholar] [CrossRef]
  126. Karch, S.; Dellile, M.-F.; Guillet, P.; Mouchet, J. African malaria vectors in European aircraft. Lancet 2001, 357, 235. [Google Scholar] [CrossRef]
  127. Caballero, J.D.; Wheatley, R.M.; Kapel, N.; López-Causapé, C.; Van der Schalk, T.; Quinn, A.; Shaw, L.P.; Ogunlana, L.; Recanatini, C.; Xavier, B.B.; et al. Mixed strain pathogen populations accelerate the evolution of antibiotic resistance in patients. Nat. Commun. 2023, 14, 1–12. [Google Scholar] [CrossRef]
  128. Rasheed, M.U.; Thajuddin, N.; Ahamed, P.; Teklemariam, Z.; Jamil, K. Antimicrobial drug resistance in strains of Escherichia coli isolated from food sources. Rev. Inst. Med. Trop. Sao Paulo 2014, 56, 341–346. [Google Scholar] [CrossRef]
  129. Doshi, S.; Shin, S.; LaPointe-Shaw, L.; Fowler, R.A.; Fralick, M.; Kwan, J.L.; Shojania, K.G.; Tang, T.; Razak, F.; Verma, A.A. Temporal clustering of critical illness events on medical wards. JAMA: Intern. Med. 2023, 183, 924–932. [Google Scholar] [CrossRef]
  130. Stephenson, L. The impact of schistosomiasis on human nutrition. Parasitol. 1993, 107, S107–S123. [Google Scholar] [CrossRef]
  131. Campos, M.C.; Castro-Pinto, D.B.; Ribeiro, G.A.; Berredo-Pinho, M.M.; Gomes, L.H.; da Silva Bellieny, M.S.; Goulart, C.M.; Echevarria, A.; Leon, L.L. P-glycoprotein efflux pump plays an important role in Trypanosoma cruzi drug resistance. Parasitol. Res. 2013, 112, 2341–2351. [Google Scholar] [CrossRef] [PubMed]
  132. Rodriguez-Duran, J.; Pinto-Martinez, A.; Castillo, C.; Benaim, G. Identification and electrophysiological properties of a sphingosine-dependent plasma membrane Ca2+ channel in Trypanosoma cruzi. FEBS J. 2019, 286, 3909–3925. [Google Scholar] [CrossRef] [PubMed]
  133. Gezelle, J.; Saggu, G.; Desai, S.A. Promises and Pitfalls of Parasite Patch-clamp. Trends Parasitol. 2021, 37, 414–429. [Google Scholar] [CrossRef] [PubMed]
Ijms 25 09775 g001
Figure 1. Transient receptor potential (TRP) for divalent cations (shown for Ca2+).
Figure 1. Transient receptor potential (TRP) for divalent cations (shown for Ca2+).
Ijms 25 09775 g001
Ijms 25 09775 g002
Figure 2. Calcium transporting pump system: initiation of host inflammatory cascade following attack by pathogen.
Figure 2. Calcium transporting pump system: initiation of host inflammatory cascade following attack by pathogen.
Ijms 25 09775 g002
Table 1. a. Molecular actions of calcium (Ca2+). b. Toxicity of pathological concentrations of divalent cations.
Table 1. a. Molecular actions of calcium (Ca2+). b. Toxicity of pathological concentrations of divalent cations.
a
Blood Coagulation
Conformational changes allow prothrombin to bind efficiently to phospholipid surfaces
Promotes platelet adhesion to blood vessel endothelium with von Willebrand factor
Bone Cortex
With phosphate increases mass during growth phase
With phosphate and exercise increases strength
Cell Signaling
Stimulates mitochondrial oxidation of ketoglutarate
Stimulates mitochondrial oxidation of pyruvate dehydrogenase
Digestive System
Stimulates gastric acid secretion
by Vitamin D-activated calbindin, contributes to intestinal absorption of calcium
Kidney
Reabsorbed passively by proximal tubule
Ca2+ sensing receptor controls absorption in loop of Henle
Klotho gene controls calcium absorption with transient receptor protein
Muscle
Contributes to orderly release of calcium from sarcoplasmic reticulum
Contributes to orderly return of calcium to sarcoplasmic reticulum
Increases expression of ryanodine receptor involved in Ca2+ release
Activates/deactivates actin–myosin for contraction/relaxation
b
ElementIonNeuromuscularCardiovascularGastrointestinalRenalOther
CalciumCa2++−+−lung
CadmiumCd2++++−skin
CopperCu2+++++-
IronFe2+−−++lymphatic
LeadPb2++−++skin
ManganeseMn2++++−-
MagnesiumMg2+++−−reproductive
SeleniumSe2+++++skin
SilverAg2+−−−−skin
ZincZn2++−++reproductive
Table 2. Effects of calcium-related hormones upon serum calcium concentration.
Table 2. Effects of calcium-related hormones upon serum calcium concentration.
Parathyroid Hormone
Organ level
Stimulates kidney to synthesize vitamin D
Increases calcium absorption in kidney tubule
Inhibits phosphorus absorption in kidney tubule
Decreases calcium phosphate bone mineral mass
Cooperates with vitamin D in increasing bone mass
Cell level
Increases expression of alkaline phosphatase
Increases expression of bone morphogenetic protein
Increases expression of collagen type1 alpha
Increases expression of osteoblast transcription factor (Tmem119)
Increases expression of calcium-binding protein (osteocalcin)
Vitamin D *
Organ Level
Increases intestinal absorption of calcium
Decreases cytokines of inflammation
Cell level
Inhibits inflammation cascade at nuclear factor kappa beta
Decreases cytokines of inflammation
Supports functions of macrophages
Activates nitric acid synthase in endothelial cells
Decreases expression of receptor for advanced glycolated end-products
Calcitonin
Organ level
Bone
Contracts osteoclasts
Diminishes osteoclast mobility
Decreases loss of bone mineral mass
Kidney
Decreases reabsorption of calcium, magnesium
Decreases reabsorption of phosphate
Decreases reabsorption of sodium => diuresis
Cell level
Binds to its receptors on osteoclasts
Promotes vitamin D production enzymes
  • Adenyl cyclase for regulation of cell growth by cyclic AMP (second messenger)
  • Inosityl triphosphatase for interaction with calcium/calmodulin/calcineurin cascade
* Vitamin D meets the criteria for definition of a hormone.
Table 3. Calcium metabolism in pulmonary tuberculosis.
Table 3. Calcium metabolism in pulmonary tuberculosis.
A. Vitamin D increases serum calcium level due to:
  1. Increased sunlight exposure with increased synthesis of vitamin D by skin
  2. Increased 1-alpha hydroxylase from lung, intestine in addition to kidney
  3. Overheating with dehydration
B. Parathyroid hormone increases serum calcium level due to:
  1. Lysis of bone cortex
  2. Promotion of synthesis of vitamin D
  3. Increased expression with hyperphosphatemia of kidney failure
C. Calcitonin regulates increased serum calcium levels due to
  1. Inhibition of bone cortex lysis by parathyroid hormone
  2. Increased expression during inflammation which might injure kidney function
Table 4. Reported benefits from calcium chelation therapy with EDTA.
Table 4. Reported benefits from calcium chelation therapy with EDTA.
PathologyResults
Diabetes Mellitus: decreased insulin secretionimproved glucose control
Cardiovascular Disease:
Heart: angina pectoris, use of nitroglycerinefewer events, decreased use of nitroglycerine
Vascular
Central: dizziness/vertigofewer events
Peripheral: ulcers, gangrenehealing, no amputations
Table 5. Life cycle of M Tuberculosis within the human host after exposure.
Table 5. Life cycle of M Tuberculosis within the human host after exposure.
Stage of Disease ActivityClinical EvidenceTreatment
Primary infection: dormant or latent TB infectionPulmonary nodules with hibernating pathogen (autophagy completed). Few symptoms, evidenced by skin testing and chest X-ray onlyAntibiotics per protocol *
Active but quiescent or evasive One-fourth to one-half within the macrophages (autophagy commenced). Symptoms primarily systemic (fatigue, fever, loss of appetite and weight, weakness)Antibiotics per protocol *
Active: aggressive pulmonaryPulmonary cavitation with respiratory symptoms added to aboveAntibiotics per protocol *
Active and disseminatedMiliary: multiorgan involvementMultiple antibiotics *
* Potential use of calcium ion blockade requires additional investigation.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

D’Elia, J.A.; Weinrauch, L.A. Role of Divalent Cations in Infections in Host–Pathogen Interaction. Int. J. Mol. Sci. 2024, 25, 9775. https://doi.org/10.3390/ijms25189775

AMA Style

D’Elia JA, Weinrauch LA. Role of Divalent Cations in Infections in Host–Pathogen Interaction. International Journal of Molecular Sciences. 2024; 25(18):9775. https://doi.org/10.3390/ijms25189775

Chicago/Turabian Style

D’Elia, John A., and Larry A. Weinrauch. 2024. "Role of Divalent Cations in Infections in Host–Pathogen Interaction" International Journal of Molecular Sciences 25, no. 18: 9775. https://doi.org/10.3390/ijms25189775

APA Style

D’Elia, J. A., & Weinrauch, L. A. (2024). Role of Divalent Cations in Infections in Host–Pathogen Interaction. International Journal of Molecular Sciences, 25(18), 9775. https://doi.org/10.3390/ijms25189775

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop